We provide complete descriptions of the interlocking systems that the FDA requires you to implement. These systems include:
These requirements are spread across multiple parts of the FDA regulations, so they are not always implemented in unison. The presentation unites the systems to make their implementation easier and more effective.
You will learn when written procedures are required, when (and how) to name designated individuals, when (and how) to formally designate units, what records you must keep, and when you must report to the FDA.
You will see statistical techniques that can be used to analyze corrective actions and service reports. These include histograms, scatter plots, check sheets, Pareto charts, and cause-and-effect diagrams.
Because these regulations may also span your organizational structure, this webinar is especially suited for cross functional and cross discipline teams.Why should you attend:
The "new" FDA, under Dr. Hamburg, is increasing enforcement activities. The FDA districts are increasing the inspection frequency, meaning you are more likely to be inspected. The new rules on Warning Letters means you are more likely to be cited based on the observations from an inspection. The very best approach is to ensure you understand the requirements and have them fully implemented. You must understand the full set of regulations so you can cover all the requirements. This webinar will give you the tools and techniques you will need to avoid receiving an FDA 483 or Warning Letter in this area.
If your Quality Management System (QMS), through its documented procedures, cannot answer these question quickly, and without hesitation, then you, and your team need to attend this webinar!
Areas Covered in the Session:
Who Will Benefit:
This seminar is designed for quality, regulatory, service, sales, and design people who may become involved in adverse events. In addition, Sales and Service employees are often the first to become aware of post-production problems. Design employees are often the first to recognize the need for field action. The FDA has stringent requirements for reporting, so people who may impact the timeline need to understand the requirements.
Attendees should understand service, problem reporting, corrective action, and field action processes. In addition, people in Sales or Service must recognize and report complaints or potential MDRs. Because of the cross functional and cross discipline aspects, this is an ideal opportunity for team attendance. You need to ensure that all parties get the same message. People in the following roles can especially benefit from the knowledge in this webinar: